Amphetamine disrupts P50 suppression in normal subjects.
about
Spatio-temporal dynamics of adaptation in the human visual system: a high-density electrical mapping studyComparison of sensory gating to mismatch negativity and self-reported perceptual phenomena in healthy adultsCharacterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophreniaDose-Dependent Changes in Auditory Sensory Gating in the Prefrontal Cortex of the Cynomolgus Monkey.Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression.Mice expressing constitutively active Gsalpha exhibit stimulus encoding deficits similar to those observed in schizophrenia patients.Neurophysiological biomarkers for drug development in schizophrenia.Dysregulation of thalamic sensory "transmission" in schizophrenia: neurochemical vulnerability to hallucinations.The early identification of psychosis: can lessons be learnt from cardiac stress testing?How human electrophysiology informs psychopharmacology: from bottom-up driven processing to top-down controlDopamine and semantic activation: an investigation of masked direct and indirect priming.Enhanced preattentive central nervous system reactivity in irritable bowel syndrome.Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating.Acute administration of roflumilast enhances sensory gating in healthy young humans in a randomized trial.Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels.Do COMT, BDNF and NRG1 polymorphisms influence P50 sensory gating in psychosis?The separate and combined effects of monoamine oxidase inhibition and nicotine on P50 sensory gating.The effects of sertindole on sensory gating, sensorimotor gating, and cognition in healthy volunteers.Sensory gating deficit is associated with catechol-O-methyltransferase polymorphisms in bipolar disorder.
P2860
Q27313316-02CAEC65-A638-460E-A197-2B6D319D74EEQ28266248-DB70C041-1B40-4453-B252-36929A58E007Q28727584-7AC04F2A-6996-41C6-93F7-577597267302Q30378932-617590CC-408F-494C-AF8B-9BD2E6E3A872Q30437684-C6EB9D91-0487-4AB9-B6E9-95086504766DQ30469318-7FFC0D09-6475-457E-AD25-F1F93F26B07AQ30486447-25D9D01F-A3CB-463B-9251-D350A287A574Q36262534-86D52CCF-89CF-4391-B189-FA4F2C21F7F0Q36437209-F761C4D8-EBD8-4B41-9E65-59E35D9332F8Q37798448-1E8BA396-A1F7-4221-A95D-CFB06D9538BFQ38423994-668F1A9E-AA7F-4BBF-AB8B-17D08C983650Q43438477-9BE0A367-5B9D-4FAF-B3B8-5B1EE90B07F5Q45053004-DE70299C-84DB-44F0-80C5-ACEE8722E55EQ47582520-3FCA2FF1-B5A9-4C03-A387-76D870575387Q48187686-706AE5B3-9F12-4658-BF49-6516C24DC7B7Q48332729-6119D400-8E87-4A2E-B202-5845599F5C17Q50608280-7C22C574-836F-44D0-97E3-CA120312D6C5Q50993919-C0CE2F4C-6752-4B47-BD98-626597696ECAQ51461425-6500E7C8-3866-4F05-92B0-4742CB5581E9
P2860
Amphetamine disrupts P50 suppression in normal subjects.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Amphetamine disrupts P50 suppression in normal subjects.
@en
type
label
Amphetamine disrupts P50 suppression in normal subjects.
@en
prefLabel
Amphetamine disrupts P50 suppression in normal subjects.
@en
P2093
P1476
Amphetamine disrupts P50 suppression in normal subjects.
@en
P2093
Coleman EA
Malaspina D
Sackeim HA
P304
P356
10.1016/S0006-3223(99)00034-7
P407
P577
1999-10-01T00:00:00Z